Atezolizumab in early triple-negative breast cancer: the randomized phase 3 NSABP B-59/GeparDouze trial. (nature.com)

Authors: Loibl S … Geyer CE Jr Journal: Nature Medicine Published: 2026-09-01 DOI: https://doi.org/10.1038/s41591-026-04565-6